Effects of ondansetron in early- versus late-onset alcoholics: A prospective, open-label studyKRANZLER, Henry R; PIERUCCI-LAGHA, Amira; FEINN, Richard et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 7, pp 1150-1155, issn 0145-6008, 6 p.Article

The role of anxiety in predicting drinking behaviourSLOAN, Tracy B; ROACHE, John D; JOHNSON, Bankole A et al.Alcohol and alcoholism (Oxford). 2003, Vol 38, Num 4, pp 360-363, issn 0735-0414, 4 p.Article

Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluationJOSHI, Ashwini S; PATEL, Hitesh S; BELGAMWAR, Veena S et al.Journal of materials science. Materials in medicine. 2012, Vol 23, Num 9, pp 2163-2175, issn 0957-4530, 13 p.Article

CYP2D6- and CYP3A-Dependent Enantioselective Plasma Concentrations of Ondansetron in Postanesthesia CareSTAMER, Ulrike M; LEE, Eun-Hae; RAUERS, Neele I et al.Anesthesia and analgesia. 2011, Vol 113, Num 1, pp 48-54, issn 0003-2999, 7 p.Article

Prophylactic ondansetron does not reduce the incidence of itching induced by intrathecal sufentanilWAXIER, Beverly; MONDRAGON, Shirley A; PATEL, Sonal N et al.Canadian journal of anaesthesia. 2004, Vol 51, Num 7, pp 685-689, issn 0832-610X, 5 p.Article

Ondansetron-Induced Muscular Contractures in Malignant Hyperthermia-Susceptible IndividualsJOHANNSEN, Stephan; ROEWER, Norbert; SCHUSTER, Frank et al.Anesthesia and analgesia. 2012, Vol 115, Num 4, pp 925-928, issn 0003-2999, 4 p.Article

The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibitionSCOTT, Jason A; WOOD, Margaret; FLOOD, Pamela et al.Anesthesia and analgesia. 2006, Vol 103, Num 3, pp 742-746, issn 0003-2999, 5 p.Article

ONDANSETRON PREVENTS CHANGES IN RESPIRATORY PATTERN PROVOKED BY LICL: A NEW APPROACH FOR STUDYING PRO-EMETIC STATES IN RODENTS?NGAMPRAMUAN, S; BAUMERT, M; CZIPPELOVA, B et al.Neuroscience. 2013, Vol 246, pp 342-350, issn 0306-4522, 9 p.Article

Anaphylactic reaction to ondansetronWEISS, Kenneth S.Archives of internal medicine (1960). 2001, Vol 161, Num 18, issn 0003-9926, p. 2263Article

Successful treatment of intractable palmoplantar pruritus with ondansetronDOWNS, A. M. R; KENNEDY, C. T. C.Archives of dermatology (1960). 1998, Vol 134, Num 8, pp 925-926, issn 0003-987XArticle

Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestionsSCHARMAN, E. J.Journal of toxicology. Clinical toxicology. 1998, Vol 36, Num 1-2, pp 19-25, issn 0731-3810Article

Effect of casting solvent on crystallinity of ondansetron in transdermal filmsPATTNAIK, Satyanarayan; SWAIN, Kalpana; MALLICK, Subrata et al.International journal of pharmaceutics (Print). 2011, Vol 406, Num 1-2, pp 106-110, issn 0378-5173, 5 p.Article

Involvement of 5-hydroxytryptaminergic transmission for the Mesobuthus tamulus venom-induced depression of spinal reflexes in neonatal rat in vitroMAURYA, Amar N; DESHPANDE, Shripad B.Neuroscience letters. 2010, Vol 482, Num 1, pp 35-39, issn 0304-3940, 5 p.Article

Palonosetron triggers 5-HT₃ receptor internalization and causes prolonged inhibition of receptor functionROJAS, Camilo; THOMAS, Ajit G; ALT, Jesse et al.European journal of pharmacology. 2010, Vol 626, Num 2-3, pp 193-199, issn 0014-2999, 7 p.Article

The Role of Ondansetron in the Treatment of SchizophreniaBENNETT, Allison C; VILA, Tania M.The Annals of pharmacotherapy. 2010, Vol 44, Num 7-8, pp 1301-1306, issn 1060-0280, 6 p.Article

From mouse to man : the 5-HT3 receptor modulates physical dependence on opioid narcoticsCHU, Larry F; LIANG, De-Yong; XIANGQI LI et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 3, pp 193-205, issn 1744-6872, 13 p.Article

Added ondansetron for stable schizophrenia : A double blind, placebo controlled trialAKHONDZADEH, Shahin; MOHAMMADI, Neyousha; NOROOZIAN, Maryam et al.Schizophrenia research. 2009, Vol 107, Num 2-3, pp 206-212, issn 0920-9964, 7 p.Article

Reduced maintenance of complete protection from emesis for women during chemotherapy cyclesLIAW, Chuang-Chi; CHANG, Hsien-Kun; LIAU, Chi-Ting et al.American journal of clinical oncology. 2003, Vol 26, Num 1, pp 12-15, issn 0277-3732, 4 p.Article

An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantationOSOWSKI, C. L; DIX, S. P; LYNN, M et al.Supportive care in cancer. 1998, Vol 6, Num 6, pp 511-517, issn 0941-4355Article

In vivo expression of ganglionic long-term potentiation in superior cervical ganglia from hypertensive aged ratsALZOUBI, K. H; ALEISA, A. M; ALKADHI, K. A et al.Neurobiology of aging. 2010, Vol 31, Num 5, pp 805-812, issn 0197-4580, 8 p.Article

Studies on Optimizing In Vitro Transdermal Permeation of Ondansetron Hydrochloride Using Nerodilol, Carvone, and Limonene as Penetration EnhancersKRISHNAIAH, Yellela S. R; RAJU, Vengaladasu; MANTRI SHIVA KUMAR et al.Pharmaceutical development and technology. 2008, Vol 13, Num 3, pp 177-185, issn 1083-7450, 9 p.Article

Supplemental 80% oxygen does not attenuate post- operative nausea and vomiting after breast surgeryPURHONEN, S; NISKANEN, M; WÜSTEFELD, M et al.Acta anaesthesiologica scandinavica. 2006, Vol 50, Num 1, pp 26-31, issn 0001-5172, 6 p.Article

Ondansetron does not block tramadol-induced analgesia in miceERHAN, E; ONAL, A; KOCABAS, S et al.Methods and findings in experimental and clinical pharmacology. 2005, Vol 27, Num 9, pp 629-632, issn 0379-0355, 4 p.Article

Ion pair formation as a possible mechanism for the enhancement effect of lauric acid on the transdermal permeation of ondansetronDIMAS, Dimitrios A; DALLAS, Paraskevas P; REKKAS, Dimitrios M et al.Pharmaceutical development and technology. 2004, Vol 9, Num 3, pp 311-320, issn 1083-7450, 10 p.Article

Utilización de ondansetrón en urgencias de pediatría = Ondansetron use in paediatric emergenciesSANCHEZ ETXANIZ, J; PANIAGUA CALZON, N; GOMEZ CORTES, B et al.Anales de pediatria (2003. Ed. impresa). 2010, Vol 72, Num 5, pp 369-370, issn 1695-4033, 2 p.Article